Bełtowski J
Katedra i Zakład Patofizjologii, Akademii Medycznej w Lublinie.
Postepy Hig Med Dosw. 1999;53(1):99-123.
Adrenomedullin (ADM) is a recently discovered peptide with potent vasorelaxing and natriuretic properties originally isolated from human pheochromocytoma. Adrenomedullin has been reported to be present in normal adrenal medulla, heart, lung and kidney as well as in plasma and urine. ADM shares some structural homology with calcitonin gene related peptide (CGRP). ADM acts on target cells through its unique receptors and CGRP1 receptors. In both cases cyclic AMP seems to be the main second messenger. ADM may function as a circulating hormone and as an autocrine/paracrine mediator involved in the regulation of cardiovascular system and renal function. Plasma concentration of ADM is elevated in patients with congestive heart failure, arterial hypertension, pulmonary hypertension, renal failure and sepsis suggesting its role in pathophysiology of these disorders. Recently another product od adrenomedullin gene, proadrenomedullin N-terminal 20-peptide (PAMP) has been described. This peptide has also vasodilating activity resulting from its inhibitory action on norepinephrine release from sympathetic endings and adrenal medulla.
肾上腺髓质素(ADM)是一种最近发现的肽,具有强大的血管舒张和利钠特性,最初是从人嗜铬细胞瘤中分离出来的。据报道,肾上腺髓质素存在于正常肾上腺髓质、心脏、肺和肾脏以及血浆和尿液中。ADM与降钙素基因相关肽(CGRP)具有一些结构同源性。ADM通过其独特的受体和CGRP1受体作用于靶细胞。在这两种情况下,环磷酸腺苷似乎都是主要的第二信使。ADM可能作为一种循环激素以及一种自分泌/旁分泌介质,参与心血管系统和肾功能的调节。充血性心力衰竭、动脉高血压、肺动脉高压、肾衰竭和脓毒症患者的血浆ADM浓度升高,表明其在这些疾病的病理生理学中发挥作用。最近,肾上腺髓质素基因的另一种产物——肾上腺髓质素原N端20肽(PAMP)已被描述。这种肽也具有血管舒张活性,这是由于它对交感神经末梢和肾上腺髓质去甲肾上腺素释放的抑制作用所致。